Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Crestor Safety Defense Misrepresents FDA Position, Agency Tells Company

Dec 22 2004

• By Sue Sutter

Related Content

Crestor, Serevent Are Among Problem Drugs Cited By FDA Safety Reviewer

Nov 18 2004

AstraZeneca Ad Minimizes Risks Posed By Highest Crestor Dose, FDA Says

Dec 22 2004

Public Citizen Takes Aim At Crestor DTC Ads Defending Statin's Safety

Nov 26 2004

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window